Biontech: Impfstoff wird bereits nach Großbritannien geliefert

SHOTLIST MAINZ, RHEINLAND-PFALZ, DEUTSCHLAND2. DEZEMBER 2020QUELLE: BIONTECH SEEINSCHRÄNKUNGEN: KEIN WEITERVERKAUF / NO RESALE1. O-TON 1 - Özlem Türeci, chief medical officer of BioNTech (Frau, English, 29 Sek.): 'Firstly we have to announce that today the first global Emergency Use Authorization has been granted for Phase 3 Clinical Data Covid-19 vaccine by the MHRA, the UK regulatory agency. We have started immediately started the process of delivering our vaccine and we expect that the roll-out of the vaccine in the UK will happen within the next couple of days.'2. O-TON 2 - Özlem Türeci, chief medical officer of BioNTech (Frau, English, 8 Sek.): 'Firstly we have to announce that today the first global Emergency Use Authorization has been granted for Phase 3 Clinical Data Covid-19 vaccine by the MHRA, the UK regulatory agency. We have started immediately started the process of delivering our vaccine and we expect that the roll-out of the vaccine in the UK will happen within the next couple of days.'